Abstract:Background Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is a reliable treatment for actinic keratosis (AK), but its effect needs to be enhanced in thick lesions. Plum-blossom needle is a traditional Chinese cost-effective instrument for enhancing the transdermal delivery of ALA. However, whether it could improve the efficacy of AK treatment has not yet been investigated. Objective To compare the efficacy and safety of plum-blossom needle–assisted PDT in facial AK in the Chinese population. Methods In this multicenter, prospective study, a total of 142 patients with AKs (grades I–III) were randomized into the plum-blossom needle–assisted PDT group (P-PDT) and control PDT group (C-PDT). In the P-PDT group, each AK lesion was tapped vertically by a plum-blossom needle before the application of 10% ALA cream. In the C-PDT group, each lesion was only wiped with regular saline before ALA cream incubation. Then, 3 hours later, all the lesions were irradiated with light-emitting diode (LED) at a wavelength of 630 nm. PDT was performed once every 2 weeks until all lesion patients achieved complete remission or completed six sessions. The efficacy (lesion response) and safety (pain scale and adverse events) in both groups were evaluated before each treatment and at every follow-up visit at 3-month intervals until 12 months. Results In the P-PDT and C-PDT groups, the clearance rates for all AK lesions after the first treatment were 57.9% and 48.0%, respectively ( P < 0.05). For grade I AK lesions, the clearance rates were 56.5% and 50.4%, respectively ( P = 0.34). For grade II AK lesions, the clearance rates were 58.0% and 48.9%, respectively ( P = 0.1). For grade III AK lesions, the clearance rates were 59.0% and 44.2%, respectively ( P < 0.05). Moreover, grade III AK lesions in the P-PDT group required fewer treatment sessions ( P < 0.05). There was no significant difference in the pain score between the two groups ( P = 0.752). Conclusion Plum-blossom needle tapping may enhance the efficacy of ALA-PDT by facilitating ALA delivery in the treatment of AK.

Real-world Data of 5-Aminolaevulinic Acid-Mediated Photodynamic Therapy for Bowen Disease: a 10-Year Retrospective Study in Patients with Darker-Coloured Skin (2011-2021).

Aminoleveulinate Photodynamic Therapy (ALA-PDT) for Bowen's Disease in a SLE Patient: Case Report and Literature Review.

Chinese Guidelines on the Clinical Application of 5-Aminolevulinic Acid-Based Photodynamic Therapy in Dermatology (2021 Edition)

Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis

Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Oral Verrucous Hyperplasia, Oral Leukoplakia and Oral Erythroleukoplakia

Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma

Effectiveness of 5-Aminolevulinic Acid Photodynamic Therapy in Treating Dissecting Cellulitis of the Scalp and Pathological Changes in Skin Lesions: A Retrospective Study

Effective treatment of actinic keratosis on the hands with red light photodynamic therapy using BF-200 ALA

Treatment of androgenetic alopecia with 5-aminolevulinic acid photodynamic therapy: A randomized, placebo-controlled, split-scalp study of efficacy and safety

5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study

Efficacy of Aminolevulinic Acid Mediated Photodynamic Therapy in the Treatment of Oral Premalignant Lesions: A Systematic Review

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study

Effectiveness of 5-aminolevulinic Acid-mediated Photodynamic Therapy Combined With Curcumin

Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split‐face control study

Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study

The Clinical Effect and Light Aging Resistant of 5-aminolevulinic Acid Photodynamic Therapy in the Treatment of Actinic Keratosis

5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study

Photodynamic Therapy for the Treatment of Basal Cell Carcinoma: A Comprehensive Review of Randomized Controlled Trials

Progression of 5-aminolevulinic Acid- based Photodynamic Therapy for Leukemia

5-Aminolaevulinic Acid-Based Photodynamic Therapy Inhibits Ultraviolet B-Induced Skin Photodamage

Topical 5-aminolevulinic acid with intense pulsed light versus intense pulsed light for photodamage in Chinese patients.